Celyad Competitors and Similar CompaniesClear all
Celyad's competitors and similar companies include Sorrento Therapeutics and Moderna.
 Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. |  Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
|  Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. | |
Founding Date | Founding Date 2007 | Founding Date 2006 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations San Diego, US HQ San Diego, US | |
Employees | Employees 1751% decrease | Employees 31019% decrease | Employees 5,60044% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2 m | Valuation ($) 22.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) €102k (FY, 2023) | Revenue (est.) $62.8m (FY, 2022) | Revenue (est.) $6.8b (FY, 2023) |
Cost of goods | Cost of goods €69k (FY, 2023) | Cost of goods N/A | Cost of goods $4.7b (FY, 2023) |
Gross profit | Gross profit €1.4m (FY, 2023) | Gross profit N/A | Gross profit $2.2b (FY, 2023) |
Net income | Net income (€8.4m) (FY, 2023) | Net income ($577.8m) (FY, 2022) | Net income ($4.7b) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 42.6m | Total funding raised $ 1.8b |
For sources of this data, please see the company profile
View Company Profiles
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View companyModerna
HQ
Cambridge, US
Employees
5,600↑ 44% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View company